Report #2827400

Received Feb 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: MD
Recovered: Unknown
Vaccinated: Jul 27, 2024
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	IM / LA

Symptoms (2)

Incomplete course of vaccinationNo adverse event

Symptom narrative

Received First Dose Heplisav-B, and Has Not Received Second Dose Yet; Initial report received on 04-Feb-2025. A pharmacist reported that a 33-year-old male received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization on 27-Jul-2024 but has not received his second dose yet. No medical history or concomitant medications were reported. On 27-Jul-2024, the patient received dose 1 of a hepatitis B vaccine HEPLISAV-B (NDC number 43528-003-05; expiration date and lot number not available) intramuscularly in the left arm. As of the date of report, 04-Feb-2025, 192 days after having received the first dose of HEPLISAV-B, the patient has not yet received his second dose. No side effects were reported. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.